General guidance
What is urologic oncology?
Urologic oncology focuses on diagnosis, treatment, and follow-up for tumors of the urinary and genital system, including prostate, bladder, kidney, and testicular cancer according to each case.
UroPanama
Specialized evaluation of suspected, diagnosed, or follow-up urologic cancer-related conditions.
A page for patients who need to review studies, understand a diagnosis, or request a specialized second opinion.

General guidance
Urologic oncology focuses on diagnosis, treatment, and follow-up for tumors of the urinary and genital system, including prostate, bladder, kidney, and testicular cancer according to each case.
When to consult
Abnormal studies or clinical suspicion.
Elevated PSA.
Blood in urine.
Prior diagnosis.
Surgical recommendation.
Need for second opinion.
Epidemiologic context
These figures are presented as population context, not as an individual diagnosis. Evaluation depends on symptoms, studies, history, and each patient's findings.
1,476
GLOBOCAN/IARC reports prostate cancer as the most common cancer in men in Panama. The page uses a verified local figure instead of the broad '1 in 6' claim.
#9
Bladder cancer appears among the ten most common cancers globally in the GLOBOCAN 2022 dataset.
What the doctor may evaluate
The visit may include review of imaging, labs, biopsies, prior medical reports, and previous treatments.
What to bring
In uro-oncology, organized records help clarify the diagnosis, suspicion, or recommendation that needs review.
You do not need every document to request a visit; however, bringing organized records helps the case be reviewed more clearly and avoids repeating important information.
Possible next steps
The focus is to review the available evidence, clarify doubts, and define whether more information is needed before discussing management options.
Each step is defined after reviewing symptoms, history, and available studies. Website guidance is educational and does not replace a medical consultation.
Organize the diagnosis, suspicion, or abnormal finding.
Review consistency between imaging, biopsy, and labs.
Identify missing information or pending studies.
Integrate uro-oncology training linked to Hospital Clínic de Barcelona and international protocols.
Discuss focal therapy or fusion prostate biopsy only when the case and studies justify it.
Discuss management options after medical evaluation.
Define whether a second opinion may add clarity.
Plan responsible and safe follow-up.
Related pages
Request evaluation for suspected or diagnosed prostate, bladder, kidney, testicular, or penile cancer, or when an imaging study shows a lesion needing specialist review. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
It is detected through medical evaluation, PSA, rectal exam, MRI, and biopsy when indicated. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
When detected early, many cases can be treated successfully. The plan depends on stage, risk, general health, and patient goals. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
Blood in the urine, urinary urgency, and persistent urinary discomfort should be evaluated, especially when there is no clear explanation. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
It may be suspected with flank pain, blood in the urine, or findings on imaging studies. Some cases are found incidentally. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
It may be related to infection, stones, inflammation, or urinary tumors. Hematuria should be evaluated even when it is not always visible. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
Bring biopsy reports, PSA, MRI, CT scans, ultrasound, lab tests, pathology reports, and any available medical summary. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
Yes. A second opinion can help review diagnosis, staging, treatment options, and priority next steps. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
The visit helps determine whether surgery, surveillance, medical treatment, additional studies, or other options are appropriate. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
Yes. You may bring a family member or trusted person, especially when reviewing studies, treatment decisions, or next steps. During the visit, the full context, available studies, and current symptoms are reviewed to guide safe next steps, without replacing medical evaluation or promising a specific outcome.
The information on this page does not replace a medical consultation. If you have blood in your urine, urinary retention, fever, severe pain, or an elevated PSA, request an evaluation with a urologist.